Financial Times FT.com

Resources

Life Sciences

Inside this issue

• Stem cell laboratories worldwide have never been busier and several approaches are showing promise

• The animal health sector is going to the dogs but that is no bad thing - -

Content

Discovery is running ahead of delivery

The industry finds itself facing a number of pressures, but is still managing to produce important innovations, reports Andrew Jack

Data management: Industry braced for information deluge

The challenge is to make sense of the facts pouring in, says Clive Cookson

Medical devices: Recalls and litigation stoke debate on rules

Andrew Jack looks at demands for a tougher ethical code

Crop science: Global food debate presents opportunity to reap a profit

There is controversy over GM companies taking advantage of world hunger, writes Jessica Twentyman

Stem cells: Labs busy as projects reach early clinical trial

Several approaches are showing promise, says Clive Cookson

Animal health: Where going to the dogs is no bad thing

Andrew Jack finds the sector is about more than just raising food output. Plus profile of Frontline, top flea product

Doctors and patients: ‘More like a conversation between equals’

Jane Bird finds the internet is having a profound effect on traditional medical relationships

China: Pharma heads east for profit

Patti Waldmeir says an expanding middle class is driving healthcare growth

US: Healthcare reform makes its mark

Some of the outcomes have not been as expected, discovers Alan Rappeport

Japan: Drug companies seek growth fillip abroad

Lindsay Whipp finds few prospects in home market